Renowned leader in the anti-infective drug industry invests in Antabio

Antabio, the biopharmaceutical antibacterial drug discovery company, welcomes M. Christophe RICARD former CEO of the Swiss pharmaceutical group OM Pharma as its new investor. Under Mr RICARD’s leadership, OM Pharma developed and commercialized two record selling drugs...

Antabio obtains financial support from Oséo

Antabio receives a grant from Oséo, the French public institution responsible for supporting innovation and growth of SME’s in France, to support its new discovery programme.